Stanford Byers Center for Biodesign

What Stanford Byers Center for Biodesign does

Stanford Byers Center for Biodesign is a nonprofit academic center within Stanford University's School of Medicine, established in 2001 to train innovators in health technology development. It operates an integrated educational platform anchored by the year-long Innovation Fellowship (the flagship program since 2001), supplemented by Faculty and Policy Fellowships, a portfolio of 13+ Stanford-accredited courses (Biodesign Fundamentals, Digital Health, Medical Device Innovation, Needs Finding, etc.), Executive Education, and global initiatives spanning India, Singapore, Japan, and East Africa. Its core intellectual asset is the "Biodesign Innovation Process" — a codified methodology for needs identification, invention, and implementation of health technologies — documented in a published textbook, a 26-module Student Guide to Biodesign online resource, case study libraries (Digital Health, Global Health, Health Equity), and an oral history archive of medical technology pioneers.

The center's revenue model is philanthropic and institutional rather than commercial. The vast majority of operating funds are raised annually through individual and foundation donations (including the Promise Program where successful alumni make nonbinding commitments upon financial exit), supplemented by corporate sponsorships from health technology companies, Stanford University core funding, and limited fee-based executive education. Stanford Biodesign's primary "customers" are trainees (fellows, Stanford students, executives) who participate in programs free of charge with stipend support, alongside industry partners who sponsor fellowships to access trained talent. Select downstream customers include health technology companies that recruit from the alumni pipeline and clinical partners (Stanford Health Care, Stanford Children's Health) that provide clinical immersion settings.

Strategically, the center functions as a talent factory and innovation methodology exporter for the medtech ecosystem, with measurable outputs including 58 companies launched, 22 million+ patients helped by Biodesign-originated products, and 500+ fellows/students/executives trained annually. As a university research center, it has no external shareholders, no venture backing, and no revenue-disclosure obligation; its strategic priorities center on expanding the methodology globally (BME-IDEA consortium, regional biodesign programs), deepening specialized domains (Impact1 for pediatric/maternal health, Health Equity, Digital Health and AI), and maintaining the alumni-driven philanthropic flywheel that funds operations.

Name

Stanford Byers Center for Biodesign

Legal name

Stanford University - Mussallem Center for Biodesign

Website

https://biodesign.stanford.edu

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Stanford Byers Center for Biodesign is a nonprofit academic center within Stanford's School of Medicine that trains health technology innovators through fellowships, courses, and global programs using its codified Biodesign Innovation Process methodology. It serves aspiring medtech innovators, Stanford students, faculty, and industry partners, having launched 58 companies and trained 500+ individuals annually since 2001.

Ownership category

akta.pro rank

Product category

Health Technology Innovation Education

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Health Informatics & Digital Health Programs (EDAHAGAJ)

Keywords

• Health technology innovation
• Medical device development
• Biomedical engineering education
• Clinical needs identification
• Innovation fellowships

Headquarters

HQ city

Stanford

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Philanthropic Donations: The center raises the vast majority of its operating funds on an annual basis through individual and foundation donations. The Promise Program allows company founders, equity holders, investors, and industry leaders to make nonbinding financial commitments when they attain financial success.
2. Industry Sponsorships: Corporate funding and fellowship sponsorships from health technology companies who support the Stanford Biodesign program and gain access to trained talent and innovation pipeline
3. Stanford University Core Funding: As a Stanford School of Medicine center, receives institutional support from Stanford University for operations, facilities, and faculty positions
4. Educational Program Fees: Executive Education programs and some specialized training offerings may generate revenue through participant fees

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Stanford Byers Center for Biodesign is an academic center within Stanford University School of Medicine that teaches and empowers health technology innovators through fellowships, Stanford courses, global programs, and learning resources. Its core offering is the Biodesign Innovation Process, a systematic methodology for identifying unmet clinical needs, inventing health technology solutions, and implementing them into patient care. The center trains individuals (fellows, faculty, students, executives) who go on to launch health technology companies, with 58 companies launched and 22 million+ patients helped to date.

Product overview

Stanford Byers Center for Biodesign is an academic center at Stanford University dedicated to health technology innovation. The center operates as an integrated platform offering educational programs, fellowships, learning resources, and global initiatives. The core programs include the Innovation Fellowship (year-long training since 2001), Faculty Fellowship, and Policy Fellowship. The educational course portfolio spans foundational courses (Biodesign Fundamentals, Biodesign Innovation), specialized tracks (Digital Health, Medical Device Innovation, Global Biodesign), and executive education. Specialized initiatives address pediatric/maternal health (Impact1), health equity, digital health and AI, and policy. Global programs extend biodesign methodology through partnerships in India, Singapore, Japan, East Africa, and with international faculty training. The center provides extensive learning resources including the Student Guide to Biodesign (26-module digital curriculum), case studies (Digital Health, Global Health, Health Equity), the Biodesign Speaker Series, research publications, and oral history archives. Career-focused offerings include Biodesign Internship Connect matching students with health tech companies. The center has trained over 500 individuals annually, launched 58 companies, and contributed to technologies helping over 22 million patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovation Fellowship Flagship year-long training program for exceptional individuals with backgrounds in healthcare, engineering, computer science/AI, or business who are passionate about transforming patient experience through technological innovation; provides personalized career coaching, industry introductions, and access to Stanford resources.
• Faculty Fellowship Training program for Stanford faculty members to develop health technology innovation skills and integrate biodesign methodology into their academic work.
• Policy Fellowship Fellowship program focused on health technology policy education and development for professionals engaged in regulatory and policy aspects of medical innovation.
• Executive Education Professional education programs for industry executives seeking to understand health technology innovation processes and the Biodesign methodology.
• Global Faculty Training Training program for international faculty members to implement biodesign methodology at their home institutions worldwide, including India, Singapore, and Japan programs.
• India Biodesign Program Partnership with India for developing and implementing biodesign health technology innovation programs, with faculty advisors and operations team supporting the regional program.
• Singapore-Stanford Biodesign Partnership with Singapore for health technology innovation training and development, spanning 2007-2019 and producing Global Fellows from Singapore institutions; established model for Asia-Pacific expansion of biodesign methodology.
• Japan Biodesign Program Partnership with Japan for biodesign innovation education and healthcare technology development across Hiroshima University, University of Tokyo, Osaka University, Nagoya University, and University of Tsukuba.
• Impact1 - Pediatric/Maternal Health Initiative Initiative focused on driving innovation for pediatric and maternal health needs, addressing the gap in medical devices designed for children through clinical immersion and project support.
• Digital Health and AI Initiative Initiative focusing on digital health technologies and artificial intelligence applications in healthcare innovation.
• Health Equity Initiative Program encouraging and equipping trainees to innovate for traditionally underserved populations and develop technologies contributing to health equity.
• Stanford Initiative for Entrepreneurs' Resilience Program supporting entrepreneurial resilience among health technology innovators.
• Promise Program Giving program enabling successful alumni (company founders, equity holders, investors, and industry leaders) to make nonbinding financial commitments to Stanford Biodesign when they attain financial success, supporting long-term sustainability.
• Grants Program Funding program including translational grants to support health technology development from Stanford Biodesign training programs.
• Stanford Biodesign Course Portfolio Combined portfolio of Stanford courses covering foundational and specialized health technology innovation: Biodesign Fundamentals, Biodesign Innovation, Biodesign for Digital Health, Biodesign for the Underserved, Bioengineering Capstone, Building for Digital Health, Global Biodesign, Medical Device Innovation, Needs Finding for Medical Students, Needs Finding in Healthcare, Pathophysiology and Design for Cardiovascular Disease, and Technology Assessment.
• Student Guide to Biodesign Free online learning resource with 26 multimedia modules covering the IDENTIFY and INVENT phases of the Biodesign approach, including videos, worksheets, templates, and case examples.
• BME-IDEA Biomedical Engineering Innovation, Design, and Entrepreneurship Alliance - an international consortium of professors in biomedical engineering programs sharing best practices for teaching innovation, design, technology transfer, and entrepreneurship.
• Biodesign Internship Connect (BIC) Program matching health technology companies and labs with Stanford students, providing internship opportunities in health tech, biotech, digital health, and life sciences, in partnership with Stanford Students in Biodesign/Biopharma (SSB).

Quantifiable outcome

• 58 companies launched from Biodesign-originated technologies
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

14 partnerships are on record, tiered core, supporting and regional.

• Stanford University Office of Technology Licensing (OTL)coreTechnology or IntegrationStanford Biodesign works closely with Stanford's OTL to help accelerate the delivery of new health technologies into patient care. OTL handles intellectual property management including disclosure, review, patenting, and licensing of technologies developed by Biodesign trainees.
• Stanford School of MedicinecoreStrategic or Co-development PartnerThe center is part of Stanford School of Medicine, providing access to clinical faculty, medical expertise, and healthcare settings for needs identification and clinical immersion.
• Stanford School of EngineeringcoreStrategic or Co-development PartnerPartnership with Stanford Engineering provides engineering expertise, technical resources, and bioengineering programs for health technology development.
• Stanford Graduate School of BusinesssupportingStrategic or Co-development PartnerCollaboration with Stanford GSB provides entrepreneurship education, business strategy expertise, and connections to venture capital community for Biodesign innovators.
• BME-IDEA (Biomedical Engineering Innovation, Design, and Entrepreneurship Alliance)coreStrategic or Co-development PartnerInternational consortium initiated by Stanford Biodesign faculty (Paul Yock, Christine Kurihara) that shares experiences and best practices across biomedical engineering programs. Expanded to Europe (2013) and Asia-Pacific (2016), with efforts underway for Africa and South America.
• Stanford Students in Biodesign/Biopharma (SSB)coreChannel Partner/ Reseller/ DistributorStanford's premier on-campus student organization with 200+ engineering and life science students. Partners with Biodesign to operate Biodesign Internship Connect (BIC) program matching students with health tech opportunities.
• Stanford Health CarecoreStrategic or Co-development PartnerClinical partner providing clinical immersion opportunities for fellows and students to observe clinical needs firsthand in adult care settings.
• Stanford Children's HealthcoreStrategic or Co-development PartnerClinical partner providing pediatric clinical immersion opportunities, including through the Impact1 initiative focused on pediatric and maternal health innovation.
• India Biodesign ProgramregionalStrategic or Co-development PartnerGlobal translation and outreach initiative including India Program with faculty advisors (Michele Barry, Rajiv Doshi) and operations team (Saloni Doshi, Mohit Singhala). Part of Stanford's Global Health Consortium for Innovation.
• Singapore-Stanford BiodesignregionalStrategic or Co-development PartnerInternational partnership spanning 2007-2019 producing Global Fellows from Singapore institutions. Established model for Asia-Pacific expansion of biodesign methodology.
• Japan BiodesignregionalStrategic or Co-development PartnerGlobal Faculty Training program with Japan including Hiroshima University, University of Tokyo, Osaka University, Nagoya University, University of Tsukuba. Fumiaki Ikeno serves as US Program Director.
• Stanford Silicon Valley ArchivessupportingStrategic or Co-development PartnerCollaborative initiative launched in 2019 to record oral histories of health technology pioneers and collect related documentation on medical technology innovation.
• Fogarty InnovationsupportingGTM or Marketing PartnerPartnership with Fogarty Innovation provides Medtech Trailblazers video/podcast content and additional learning resources for the Biodesign community.
• Clinical Faculty Leadership NetworkcoreStrategic or Co-development PartnerStanford School of Medicine faculty from multiple departments (Cardiology, Surgery, Radiology, etc.) who host clinical immersion and provide ongoing guidance to fellowship teams.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• BioInnovate Ireland: BioInnovate Ireland is a fellowship program based at the University of Galway that applies the Stanford Biodesign methodology to medical device innovation in Ireland and Europe. It represents the international replication of the biodesign model that Stanford helped seed globally.
• CIMIT: CIMIT (Center for Integration of Medicine and Innovative Technology) is a Boston-based consortium of academic and medical institutions accelerating health technology innovation. It funds cross-institutional medtech collaborations and clinician-led innovation, occupying a similar role in the Northeast that Stanford Biodesign plays on the West Coast.
• University of Minnesota Medical Devices Center: The University of Minnesota Medical Devices Center is a biodesign-inspired program that offers fellowships and training in medical device innovation, with similar clinical immersion and prototyping workflows. It is one of the established U.S. academic biodesign-style programs.
• Fogarty Innovation: Fogarty Innovation is a Menlo Park-based medical technology innovation institute founded by Dr. Thomas Fogarty that trains and supports health technology innovators. It is an explicit Stanford Biodesign partner (providing Medtech Trailblazers content) and operates a parallel medtech-focused fellowship and incubator model.
• Johns Hopkins Center for Bioengineering Innovation and Design (CBID): CBID is Johns Hopkins University's graduate program in biomedical design and innovation, modeled directly after the Stanford Biodesign methodology. It trains multidisciplinary teams through clinical immersion, needs finding, and medical device prototyping, making it one of the closest U.S. academic peers.
• UCLA Biodesign: UCLA Biodesign is the University of California, Los Angeles's health technology innovation program that trains multidisciplinary teams in medical device and digital health innovation. It is a direct domestic academic peer that also adopts the biodesign framework.
• Imperial College London Helix Centre: The Helix Centre is a joint Imperial College London and Royal College of Art design-led healthcare innovation program focused on clinical immersion and unmet needs identification. It applies a similar human-centered design methodology to healthcare innovation in the UK.
• MIT linQ: MIT linQ (formerly MIT Catalyst) is MIT's medical technology innovation program that brings together engineers, clinicians, and entrepreneurs to translate clinical needs into commercial medtech solutions. It offers a comparable fellowship and project-based training model to Stanford Biodesign.
• UCSF Rosenman Institute: UCSF Rosenman Institute is a University of California, San Francisco health technology innovation platform that supports clinician-innovators and health tech startups. It runs fellowship and accelerator-style programs analogous to Stanford Biodesign and serves the same Bay Area clinical-innovation ecosystem.

Broad incumbents

• Mount Sinai Innovation Partners: Mount Sinai Innovation Partners is the technology transfer and commercialization arm of the Mount Sinai Health System in New York. It focuses on commercializing internal research and supporting health tech ventures, making it a broader incumbent in the same health innovation ecosystem rather than a direct training-focused peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/stanfordmed
• YouTubeyoutube.com/channel/UCw0jLaaM53RS4jn_HSe1Qnw
• Facebookfacebook.com/stanfordbiodesign
• LinkedInlinkedin.com/company/stanford-byers-center-for-biodesign
• Instagraminstagram.com/stanfordbiodesign

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stanford Byers Center for Biodesign